Improving Surgical Choices for Young Women with Breast Cancer
Optimizing Surgical Decisions in Young Adults With Breast Cancer
Recruiting
N/A
Interventional Study
Breast Cancer Stage 0
Breast Cancer Stage I
Breast Cancer Stage II
Breast Cancer Stage III
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 44
- Sex
- Female
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 800 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Other
Who this trial is looking for
This trial is looking for young women who have been newly diagnosed with breast cancer. Participants will use a web-based tool to help them make surgical decisions and will complete surveys about their experience related to surgery.
Are You a Good Fit for This Trial?
You may be able to join if
- I am a female aged 18-44
- I have been diagnosed with Stage 0, 1, 2, or 3 unilateral breast cancer
- I speak English or Spanish
You may not be able to join if
- I have been diagnosed with Stage 4 breast cancer
- I have recurrent early-stage breast cancer
- I have bilateral breast cancer
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female aged 18-44
* New diagnosis of Stage 0, 1, 2, or 3 unilateral breast cancer
* English or Spanish speaking
Exclusion Criteria:
* Diagnosis of de novo Stage 4 breast cancer
* Recurrent early-stage breast cancer
* Bilateral breast cancer
Contacts